findmyKOL

Thomas Saphner, MD

Basic profile

Medical Oncology

ORCIDNone on fileNPI
RegionGreen Bay, WI · MidwestSpecialtyMedical OncologyFocusOncology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationNot yet indexedOnline presenceNot yet checkedPayments2021 onwardNIH funding2002–2025Why? →

Thomas Saphner is an Oncology physician.

Overview

Scholarship

indexed output and impact (OpenAlex)

Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →

Clinical & industry

trials, payments and federal funding
1companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments
2NIH grants · 2002–2025

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1726 Shawano Ave
Green Bay, WI 543033216

Telephone

920-884-3135

Provider last certified this registry record 18 Nov 2021.

View the NPPES registry record

Industry payments

1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    53.8%
    Aromatase Inhibitor18.4%
    Anastrozole100%
    Part D38 patients
    Cytochrome P450 17A1 Inhibitor15.6%
    Abiraterone Acetate100%
    Part D14 patients

    + 4 more classes in this area

  • Metabolism & gastrointestinal

    16.7%
    Corticosteroid14.5%
    Prednisone100%
    Part D22 patients
    Serotonin-3 Receptor Antagonist2.2%
    Ondansetron Hcl100%
    Part D11 patients
  • Nervous system

    13.8%
    Phenothiazine11.4%
    Prochlorperazine Maleate100%
    Part D35 patients
    Opioid Agonist2.4%
    Morphine Sulfate Er100%
    Part D<11 patients
Where care is delivered (Part B)9.6% facility · 90.4% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

2 NIH research awards on record, funded 20022025 per NIH RePORTER. The latest:

20 more award records behind the reveal.Reveal →

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”